S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

IGMS IGM Biosciences Inc

6.90

-0.15 (-2.13%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Date of Notice

12/14/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Fred Schwarzer

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more IGM Biosciences Charts.

IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more IGM Biosciences Charts.

IGM Biosciences Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 16 December 2024 (6 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 16 December 2024 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Friday 8 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

More IGM Biosciences Inc News Articles

GNCC Capital (CE)

Intergrated Cannabis Sol... (PK)

Asia Broadband (PK)

North Bay Resources (PK)

Elite Pharmaceuticals (QB)

Lightwave Logic

Digital Brand Media and ... (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions